PEPTIDE BASED TUMOR TARGETING TECHNOLOGY

Brand Owner (click to sort) Address Description
ALPHALEX Cybrexa, Inc. 5 Science Park New Haven CT 06511 Peptide based tumor targeting technology, namely, a synthetic peptide attached via a self immolating chemical linker to an active pharmaceutical drug that specifically delivers active pharmaceutical drugs into the tumor cells while sparing normal tissues utilizing the low pH conditions of the tumor micro environment;
ALPHALEX Cybrexa, Inc. 5 Science Park New Haven CT 06511 Peptide based tumor targeting technology, namely, a synthetic peptide attached via a self immolating chemical linker to an active pharmaceutical drug that specifically delivers active pharmaceutical drugs into the tumor cells while sparing normal tissues utilizing the low pH conditions of the tumor micro environment;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides a peptide marker targeting to nasopharyngeal carcinoma (NPC) cells and application thereof. The peptide binds specifically to the cell surface of NPC cells. After conjugated with liposome containing chemotherapeutic drugs, such peptides deliver chemotherapeutic drugs to the tumor cells specifically and destruct tumor cells without damaging normal tissues and organs. Furthermore, such peptide is applied as a detector in the development of NPC diagnosis kit.